| Date | Title | Description |
| 09.06.2025 | Zero Networks: $55 Million Series C Closed To Transform Network Security | Zero Networks, the cybersecurity company reclaiming microsegmentation to deliver on its promise, announced it raised $55 million in Series C funding. The funding round was led by Highland Europe, with participation from existing investors F... |
| 04.06.2025 | Zero Networks: A Cybersecurity Phoenix Rises with $55 Million Funding | In the digital age, cybersecurity is the fortress that guards our most valuable assets. As cyber threats evolve, so must our defenses. Enter Zero Networks, an Israeli startup that has just raised $55 million in a Series C funding round. Thi... |
| 03.06.2025 | Zero Networks raises $55 million to expand microsegmentation and zero-trust solutions
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our missio... | Israeli cybersecurity startup Zero Networks Ltd. announced today that it has raised $55 million in new funding to expand its team and scale up go-to-market efforts worldwide.
Founded in 2019, Zero Networks offers automated, agentless micros... |
| 03.06.2025 | Zero Networks Raises $55M in Series C Funding | Zero Networks, an Orlando, FL-based cybersecurity company, raised $55M in Series C funding.
The round, which brought total funding to more than $100M, was led by Highland Europe, with participation from existing investors F2 Venture Capital... |
| 20.05.2025 | Adyton Secures $11 Million to Revolutionize Military Operations | In a world where speed and precision can mean the difference between victory and defeat, Adyton has emerged as a game-changer. The Dallas-based company recently secured $11 million in funding, a lifeline that promises to reshape how the U.S... |
| 18.05.2025 | Adyton: $11 Million Secured For Digitizing And Automating Operational Processes | Adyton announced $11 million in funding, led by Venrock with participation from Khosla Ventures, Liquid 2 Ventures, Alumni Ventures, Initialized Capital, Kindred Ventures, and Leblon Capital. The company also revealed a multi-year deal wort... |
| 15.05.2025 | Adyton Raises $11M in Funding | Adyton, a Dallas, TX-based provider of an operations kit digitizing and automating Department of Defense operations, raised $11M in funding.
The round was led by Venrock with participation from Khosla Ventures, Liquid 2 Ventures, Alumni Ven... |
| 02.05.2025 | Astronomer’s $93 Million Bet on Data Pipelines: A New Era for DataOps | In the fast-paced world of technology, data is the new oil. Companies are racing to refine it, to extract insights that drive decisions. Astronomer Inc. is at the forefront of this race, recently securing a hefty $93 million in Series D fun... |
| 02.05.2025 | Astronomer Secures $93 Million Series D Funding to Deliver Unified DataOps Platform for Enterprise AI | Financing led by Bain Capital Ventures, alongside Salesforce Ventures and all existing investors, with Bosch Ventures seeking to participate, will drive global expansion and accelerate R&D
Astronomer, the company behind Astro, the leadi... |
| 02.05.2025 | Astronomer: $93 Million Series D Raised For DataOps Platform | Astronomer (the company behind Astro, a leading unified DataOps platform powered by Apache Airflow) announced it has secured $93 million in Series D funding led by Bain Capital Ventures, along with Salesforce Ventures and existing investors... |
| 01.05.2025 | Astronomer’s $93M raise underscores a new reality: Orchestration is king in AI infrastructure | Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More
Astronomer, the company behind the Apache Airflow-powered data orchestration platform Astro, has secured $93 mill... |
| 01.05.2025 | Astronomer Raises $93M in Series D Funding | Astronomer, a NYC-based provider of a unified DataOps platform powered by Apache Airflow®, raised $93m in Series D funding.
The round was led by Bain Capital Ventures, with participation from Salesforce Ventures and existing investors inclu... |
| 03.04.2025 | Suki Launches AI Prescription Order Generation from Ambient Visits | What You Should Know:
– Suki, the leader in artificial intelligence (AI) technology for healthcare, today announced the industry’s first-ever capability to generate and stage prescription orders from ambient visits.
– This new feature will ... |
| 20.03.2025 | With $6.2B Purchase Of Chip Designer Ampere, SoftBank Is Going Big This Year | 0 Shares Email Facebook Twitter LinkedIn
As an investor, SoftBank is known for going big.
That mentality came across clearly Wednesday evening, when the storied tech dealmaker announced it will acquire chip design company Ampere Computing, ... |
| 28.02.2025 | The Rise of Auditoria.AI: Transforming Corporate Finance with Agentic AI | In the bustling tech landscape of Silicon Valley, innovation is the lifeblood of progress. Among the myriad of startups, Auditoria.AI stands out like a lighthouse in a storm. This San Jose-based company has just secured $38 million in Serie... |
| 25.02.2025 | Auditoria.AI Raises $38M in Series B Funding | Auditoria.AI, a San Jose, CA-based company which specializes in agentic AI for the Office of the Chief Financial Officer (CFO), raised $38M in Series B funding.
The round was led by Innovius Capital with participation from Dell Technologies... |
| 25.02.2025 | Auditoria.AI raises $38 million | Auditoria.AI Auditoria.AI
Founded: 2019
Headquarters: San Jose, California, United States
Total Funding: $59.5M
See full company profile "> , an AI-powered finance automation platform, has raised $38 million in Series B funding led ... |
| 06.02.2025 | GenLogs Secures $14.6M to Revolutionize Freight Intelligence | In the fast-paced world of logistics, data is the new gold. GenLogs, a freight intelligence platform based in Arlington, Virginia, has struck a rich vein with its recent $14.6 million Series A funding round. This infusion of capital, led by... |
| 05.02.2025 | GenLogs Raises $14.6M in Series A Funding | GenLogs, an Arlington, VA-based provider of a freight Intelligence platform raised $14.6M in Series A funding.
The round was led by Venrock and HOF Capital, with participation from Steel Atlas, AutoTech Ventures, Venture53, TitletownTech, P... |
| 03.02.2025 | GenLogs Raises $14.6M Series A Led by Venrock, HOF Capital to Drive Freight Efficiency and Security | GenLogs' Intermodal Insights
GenLogs' Asset Locator Tool
GenLogs Founding Team (L-R): Joe Sherman (CTO), Ryan Joyce (CEO), Blake Balch (CSO)
The GenLogs Freight Intelligence platform is quickly becoming one of the most indispensable tools o... |
| 23.01.2025 | The Dance of Deals: China’s Biopharmaceuticals and India’s Renewable Energy | In the world of business, deals are like dances. They require rhythm, timing, and the right partners. Recently, two significant transactions emerged from Asia, showcasing the dynamic interplay between innovation and investment. One involves... |
| 21.01.2025 | China's KeyMed, InnoCare Grant Prolium Bio Global Rights to Cancer Drug for USD520 Million | (Yicai) Jan. 21 -- KeyMed Biosciences and InnoCare Pharma have granted RTW Investments-backed Prolium Bioscience exclusive global rights to a novel antibody-drug conjugate still in clinical trials, with the deal potentially worth more than ... |
| 16.01.2025 | Timberlyne Therapeutics: $180 Million (Series A) Raised For Advancing CM313 | Timberlyne Therapeutics – a clinical-stage biopharmaceutical company focused on the development of novel therapies for autoimmune disorders – announced the closing of a $180 million Series A financing to advance CM313, a potentially best-in... |
| 13.01.2025 | Timberlyne: $180 Million (Series A) Raised To Develop Novel Therapies For Autoimmune Disorders | Timberlyne Therapeutics, a clinical-stage biopharmaceutical company focused on the development of novel therapies for autoimmune disorders, announced the closing of a $180 million Series A financing to advance CM313, a potentially best-in-c... |
| 22.11.2024 | Metsera: $215 Million (Series B) Raised To Develop Medicines For Obesity And Metabolic Diseases | Metsera – a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases – announced the closing of a $215 million Series B funding round to further advance its portfolio of highl... |
| 14.11.2024 | Metsera Raises $215M in Series B Financing | Metsera, a NYC-based clinical-stage biopharmaceutical company, raised $215M in Series B funding.
The round was led by Wellington Management and Venrock, with participation from Fidelity Management and Research Company, Janus Henderson Inves... |
| 30.10.2024 | GlycoMimetics To Acquire Crescent Biopharma | GlycoMimetics (NASDAQ: GLYC), a Rockville, MD-based late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers, acquired Crescent Biopharma, Inc., a biotechnology company advancing a pipeli... |
| 25.10.2024 | Interos: $40 Million Raised From Blue Owl Capital | Interos, a leader in AI-based supply chain risk intelligence trusted by over 100 Fortune 1000 companies and numerous leading federal agencies, announced a strategic $40 million growth capital investment from funds managed by Blue Owl Capita... |
| 24.10.2024 | Jade Biosciences Extends Financing; Total To $95M | Jade Biosciences, a Vancouver, BC, Canada-based biotechnology company dedicated to developing therapies for patients living with autoimmune diseases, extended its financing, bringing the total raised to $95M.
The round added Frazier Life Sc... |
| 15.10.2024 | Suki: AI-Based Healthcare Leader Raises $70 Million (Series D) | Suki, a leader in artificial intelligence (AI) technology for healthcare, announced $70 million in new funding on the strength of its health system and electronic health record (EHR) partnerships, including collaborations with Epic, Oracle ... |
| 14.10.2024 | Scope3: Collaborative Sustainability Platform Company Raises $25 Million | Scope3, a collaborative sustainability platform decarbonizing media and advertising, announced the closing of $25 million in a strategic funding round led by GV. The funding round included participation from existing investors Venrock, Room... |
| 11.10.2024 | Scope3 Raises $25M in Funding to Expand into Sustainable AI | Scope3, the collaborative sustainability platform decarbonizing media and advertising, announced the closing of $25 million in new funding led by GV. The round included participation from existing investors Venrock, Room40 Ventures, and Cra... |
| 10.10.2024 | Suki's $70 Million Leap: Revolutionizing Healthcare with AI | In the fast-paced world of healthcare, Suki is making waves. The company recently secured $70 million in funding, pushing its total to $165 million. This investment, led by Hedosophia and backed by Venrock and other existing investors, aims... |
| 10.10.2024 | Scope3 Raises $25 Million in Funding to Expand into Sustainable AI | Scope3, the collaborative sustainability platform decarbonizing media and advertising, today announced the closing of $25 million in new funding led by GV. The round included participation from existing investors Venrock, Room40 Ventures, a... |
| 10.10.2024 | Suki Secures $70 Million Series D Funding as Demand Surges, Expands Strategic Partnership with MedStar Health | Unprecedented growth, including 12+ new health system partnerships and expansion with MedStar Health, drives latest investment
Related Posts
The Role of AI in Protecting Consumers and Businesses From Modern Fraud
Oct 11, 2024
AMD Launches 5... |
| 10.10.2024 | Suki Raises $70M to Advance AI-Powered Solutions for Healthcare | What You Should Know:
– Suki, a provider of artificial intelligence (AI) technology for healthcare raises $70M in new funding, bringing its total funding to $165M.
– The investment, led by Hedosophia with significant participation from Venr... |
| 10.10.2024 | Suki raises $70M for its healthcare-focused AI assistant
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to provide free, deep, and ... | Suki AI Inc., a startup with an artificial intelligence assistant for healthcare professionals, has raised $70 million in funding to enhance its technology.
London-based fund Hedosophia led the Series D investment. Suki said in its announce... |
| 10.10.2024 | Suki secures $70M to enhance its AI ambient scribe offerings | Photo: Hero Images Inc./Getty Images
Suki, maker of an AI-backed healthcare voice tool, announced it raised $70 million in Series D funding, bringing its total raise to $165 million.
Hedosophia led the round, with additional investment from... |
| 01.10.2024 | The 10 Biggest Rounds Of September: Safe Superintelligence’s $1B Raise Reigns Supreme | 1 Shares Email Facebook Twitter LinkedIn
This is a monthly feature that runs down the month’s top 10 funding rounds in the U.S. Check out the biggest rounds of last month here.
Lots of big rounds as summer fades into fall. AI startup Safe S... |
| 20.08.2024 | Vanilla: Estate Planning Software Company Raises Strategic Funding | Estate planning software company Vanilla announced a strategic funding round led by returning investor Insight Partners, with participation from Venrock, Vanguard, and other previous investors. Vanilla also welcomes new strategic investor E... |
| 25.07.2024 | Element Biosciences: A New Era in DNA Sequencing**
** | ** Element Biosciences is on a mission. The San Diego-based company is reshaping the landscape of DNA sequencing and multi-omics technology. With a recent infusion of over $277 million in Series D funding, Element is poised to democratize a... |
| 23.07.2024 | Element Biosciences: Over $277 Million In Series D Raised For Democratizing Access To Advanced Biological Tools | Element Biosciences, a developer of pioneering technologies to empower science, announced over $277 million in Series D funding to support its growing global customer base with disruptive DNA sequencing and multi-omics technologies for year... |
| 26.06.2024 | CASI Pharmaceuticals Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu He | BEIJING, June 26, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI) ("CASI" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of innovative therapeutic and ... |
| 17.06.2024 | Bright Peak Therapeutics raises USD90 million to advance lead program into clinical trials |
Bright Peak Therapeutics is a biotechnology company advancing a portfolio of multifunctional immunotherapies to treat cancer and other diseases. “We are now well positioned to bring much needed innovation to the field of anti-PD-1 immune-c... |
| 08.01.2024 | Exclusive: Venrock ups its find size for the first time in a decade, raising $650M for tenth fund | It was mid-December as Venrock partner Bryan Roberts waltzed into one of the conference rooms of the venture capital firm he’s been running since 2007—his German Shepherd close at his heels with a tennis ball.
When I asked how he’s been, he... |
| 26.06.2023 | Pharvaris obtains $70 million in a private placement round | |
| 21.06.2023 | Aledade Raises $260M to Expand Services for Network of Primary Care Practices | What You Should Know:
Aledade, a Bethesda, MD-based network of independent primary care practices raises $260M in a Series F funding round led by new investor Lightspeed Venture Partners, with participation from Venrock, Avidity Partners, O... |
| 14.09.2022 | YC’s 1st Health and Bio Summit | We’re excited to announce the first YC Health and Bio Summit that will take place in San Francisco on October 21, 2022.
The half day conference will feature bio and healthcare founders and investors who will tell their stories and share ad... |
| 01.06.2022 | This is the beginning of the unbundled database era | Ethan Batraski Contributor
Share on Twitter
Ethan Batraski is a partner at Venrock and focuses on data infrastructure, open source and developer tools.
More posts by this contributor
Eight trends accelerating the age of commercial-ready qua... |
| 22.02.2022 | Zero Networks Raises $20M Led by Venrock to Expand Pioneering, Effortless Segmentation to Stop the Spread of Ransomware | “Solutions today fail to protect enterprises from lateral movement and ransomware because they're expensive and cumbersome to deploy. Zero Networks’ MFA-based approach simplifies one of the hardest problems in cyber security regardless of c... |
| 04.01.2022 | Silicon Valley Investors Haven’t Let the Theranos Scandal Change the Way They Do Business | Many Silicon Valley venture capitalists continued to invest on promising new health technology start-ups as Theranos founder Elizabeth Holmes stood trial on charges of defrauding investors and patients. Even in the wake of the infamous scan... |
| 07.12.2021 | Suki Secures $55M for Voice-Enabled Clinical Assistants to Relieve Physician Burnout | What You Should Know:
– Suki raises $55M in Series C funding to expand its AI-enabled, voice-enabled clinical assistants to relieve physician burnout.
– Suki will use this funding to make strategic investments that will lead to an expansion... |
| 30.08.2021 | Vanilla Raises $11.6 Million With Venrock, Announces High-Profile Partners, Welcomes Former Vanguard Group Chairman McNabb to Board | Vanilla’s breakthrough service integrates the financial and legal sides of estate planning and automates complex estate planning logic. It creates a valuable new revenue stream for advisors and greatly increases their retention and prospect... |
| 19.08.2021 | Let’s make a deal: A crash course on corporate development | Todd Graham Contributor
Share on Twitter
Todd Graham is vice president at Venrock, a pioneering venture capital firm established in 1969.
Wash, rinse, repeat: A startup is founded, first product ships, customers engage, and then a larger co... |
| 18.05.2021 | Click-and-mortar is a better model for healthcare | Richard Lu Contributor
Share on Twitter
Richard Lu, MBA, is a medical student at Harvard Medical School.
Jennifer Schneider Contributor
Share on Twitter
Jennifer Schneider, M.D., is an entrepreneur-in-residence at General Catalyst and the f... |
| 13.03.2021 | Why every major entertainment company will get into NFTs, according to the VC behind NBA Top Shot | NFTs are digital assets exploding in popularity and value right now.
David Pakman is a VC backing NBA Top Shot, one of the most successful mainstream NFTs.
Pakman says fans of IP like Star Wars are built-in NFT customers.
Advertisement
Non-... |
| 13.03.2021 | Why every major entertainment company will get into NFTs, according to the VC behind NBA Top Shot | David Pakman. Photo by Noam Galai/Getty Images for TechCrunch
NFTs are digital assets exploding in popularity and value right now.
David Pakman is a VC backing NBA Top Shot, one of the most successful mainstream NFTs.
Pakman says fans of IP... |
| 06.03.2021 | Crypto collectibles are set to explode, says NBA Top Shot investor. Here are 3 trends to watch. | NFTs are digital assets exploding in popularity and value right now.
David Pakman is a VC backing NBA Top Shot, one of the most successful mainstream NFTs.
Pakman says the popularity will continue growing and major brands will create their ... |
| 06.03.2021 | Crypto collectibles are set to explode, says NBA Top Shot investor. Here are 3 trends to watch. | David Pakman. Venrock
NFTs are digital assets exploding in popularity and value right now.
David Pakman is a VC backing NBA Top Shot, one of the most successful mainstream NFTs.
Pakman says the popularity will continue growing and major bra... |
| 22.01.2021 | Venrock Raises $450M Fund | Venrock, a US venture capital firm, raised a new $450m pool of capital.
Venrock 9 will enable the firm to continue its mission to invest in early stage technology and healthcare businesses that are taking novel approaches to solving importa... |
| 22.01.2021 | Venrock Raises $450M | Venrock, a US venture capital firm, raised a new $450m pool of capital.
Venrock 9 will enable the firm to continue its mission to invest in early stage technology and healthcare businesses that are taking novel approaches to solving importa... |
| 22.01.2021 | Venrock Raises $450M | Venrock, a US venture capital firm, raised a new $450m pool of capital.
Venrock 9 will enable the firm to continue its mission to invest in early stage technology and healthcare businesses that are taking novel approaches to solving importa... |
| 21.01.2021 | 8 VCs agree: Behavioral support and remote visits make digital health a strong bet for 2021 | In TechCrunch investor surveys of years past, we’ve seen a big focus on fixing what’s broken or bringing the infrastructure into the modern era. But the world has dramatically changed since the beginning of the COVID-19 pandemic.
More of us... |
| 08.01.2021 | Venrock’s Bryan Roberts on the firm’s new $450 million fund, and where it’s shopping in 2021 | Venrock, the 51-year-old firm that started as the venture arm of the Rockefeller family, has closed its ninth fund with $450 million, the same amount it raised for its last two funds. The outfit, with offices in Palo Alto, New York and Camb... |
| 16.06.2020 | What’s next for space tech? 9 VCs look to the future | Space is a special category of VC investment in the best of times — and the COVID-19 pandemic is not the best of times.
Still, investors focused on and familiar with space see a lot of opportunity in the market, regardless of any prevailing... |
| 11.06.2020 | 9 top space tech VCs on the market’s opportunities and challenges | Space is a relatively niche area of tech investing in the best of times, but COVID-19 has redrawn the landscape. What do investors who are active in this sector think about what’s changed, what hasn’t and what’s coming in the future?
We cau... |
| 12.05.2020 | Where top VCs are investing in healthcare B2B and infrastructure | Rising healthcare costs, an aging population, stifling regulations and the complexity of present-day technological offerings make the trillion-dollar healthcare industry ripe for disruption.
Not only are we finding new and innovative ways t... |
| 09.05.2020 | Moving to an ‘everything as code’ world | Engineers are great at making hard things possible. Then repeatable. Then automatable. Then run on their own. Software development has repeated this cycle over and over. We build a new capability; we make it easier to repeat with scripts, w... |
| 09.05.2020 | Moving to an ‘everything as code’ world | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Engineers are great at making hard things possibl... |
| 02.05.2020 | Venrock Closes Latest Healthcare Focused Fund, at $447M | Venrock, a Palo Alto, CA-based venture capital firm, closed its latest healthcare focused fund, at $447m.
The biotech fund, led by Bong Koh and Nimish Shah, will presumably continue to invest in such focus areas as:
– Therapeutics-Small Mol... |
| 04.03.2020 | Suki Raises $20M to Expand AI-powered, Voice-Enabled Digital Assistant for Doctors | What You Need to Know:
– Today, Suki announced a Series B funding round of $20 million, led by new investor Flare Capital Partners and including top investors like First Round and Venrock.
– In just two years, Suki has established its produ... |
| 17.01.2020 | Peter Ciriello takes over the reins at Vygon USA; Mirum Pharmaceuticals taps Ian Clements to the role of CFO | Peter Ciriello
→ Peter Ciriello has climbed to the upper echelons of the French medical device maker Vygon Group. He will run the company’s US operations from the company’s headquarters in Pennsylvania and is also ta... |
| 06.12.2019 | To measure sales efficiency, SaaS startups should use the 4×2 | Brian Ascher Contributor
Share on Twitter
Brian Ascher is a partner at Venrock, where he invests broadly across enterprise and fintech and serves on the boards of several companies, including Personal Capital, 6Sense, Socrates AI, Dynamic S... |
| 01.08.2019 | Regal Healthcare Capital Partners Closes $165 million Fund II at Hard Cap | Regal Healthcare Capital Partners, a New York-based healthcare private equity firm is pleased to announce the first and final closing of its second private equity fund, RHCP II, L.P. at the hard cap of $165 million.
Fund II, raised in less ... |
| 15.09.2018 | 40 AND UNDER: The Silicon Valley biotech stars who are backing startups aiming to cure disease, prolong life, and fix the food system | This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Putting millions of dollars into bold new technologies can be a delicate business when lives hang in the balance. But every day some of the... |
| 24.04.2018 | Term Sheet — Tuesday, April 24 | UBER’S PROMISES
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
Last year, Uber released its diversity numbers for the first time since its inception in 2009. While it’s diversity numbers wer... |
| 23.04.2018 | Venrock Raises $400M for Latest Biotech Fund | Venrock, a venture capital firm investing in technology and healthcare companies, raised $400m for its latest fund.
According to a regulatory filing, Venrock Healthcare Capital Partners III, a public and cross-over biotech fund, received su... |
| 09.04.2018 | Top 10 VCs investing in mental/behavioral health | They include Polaris Partners, .406 Ventures, Y Combinator and Khosla Ventures
Healthcare is such a massive space, one that takes up a sixth of the entire U.S. economy, that just one small piece of that pie can be extremely lucrative. Take ... |
| 08.04.2018 | Rockefeller company is going to invest in crypto currency | - |
| 28.02.2018 | CRISPR Startup Inscripta Raises $55.5m Series C to Democratize Gene-Editing | Inscripta (formerly Muse Bio) has raised a $55.5 million Series C round led by healthcare investor Mérieux Développement and Washington, DC-based private equity firm Paladin Capital Group. Existing investors Venrock, Foresite, MLS Capital, ... |
| 10.01.2018 | Why This Venture Capitalist Wants Crypto to Disrupt His Business | This article originally ran in Term Sheet, Fortune’s newsletter about deals and dealmakers. Sign up here.
Before he was a partner at Venrock, David Pakman spent 12 years as an Internet entrepreneur. He was co-founder of Apple Music Group, c... |
| 10.01.2018 | Term Sheet — Wednesday, January 10 | 5 Qs WITH A DEALMAKER
Before he was a partner at Venrock, David Pakman spent 12 years as an Internet entrepreneur. He was co-founder of Apple Music Group, co-founder of MyPlay (creator of the digital music locker), CEO of eMusic (a digital ... |
| 14.11.2017 | Obama’s former chief data scientist, DJ Patil, joins Venrock as an adviser | DJ Patil, the chief data scientist under President Barack Obama, has joined Venrock Capital as an adviser. Patil has long been a proponent of using data science and artificial intelligence to solve some of the nation’s biggest problems arou... |
| 06.11.2017 | David Beier Quoted in STAT Article: They had power and status on the East Coast. So why did these health care gurus decamp for California? To change the world | Link to STAT post
PALO ALTO, Calif. — It’s easy to think, from the headlines, that the future of health care is being forged on Capitol Hill. But the traditional centers of power and influence are losing ground — and talent — to the fertil... |
| 26.10.2017 | Devoted Raises $62M to Offer Health Insurance to Your Mom | Meet Devoted Health :
Think: a new Waltham, MA-based healthcare company that aims to launch Medicare Advantage plans in 2019, with the mission of building a health care solution good enough for Mom. Kind of like the ones built by Clover Hea... |
| 19.10.2017 | Term Sheet — Thursday, October 19 | LAYOFF CENTRAL
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
Although it’s easy to blame the all-powerful Amazon for rattling the newly-public company, Blue Apron has had a host of other is... |
| 18.10.2017 | Coursera’s chief product officer just left to become a VC | Tom Willerer, who has spent the last four years with the online education company Coursera — the last two as its chief product officer — is moving on from the outfit to become a venture capitalist.
Specifically, Willerer is joining Venrock,... |
| 21.09.2017 | Learning effects, network effects, and runaway leaders | Nick Beim Contributor
Nick Beim is a partner at Venrock and an investor in machine learning startups Dataminr and Intent Media.
More posts by this contributor
Learning effects, network effects, and runaway leaders
There’s a new economic for... |
| 22.08.2017 | Insurance navigator for freelancers and self-employed closes $23.5M Series B round | F-Prime Capital led the round with existing investors Venrock and New Enterprise Associates also participating alongside new investor Portag3 Ventures. The new capital will support the expansion of Stride Health’s benefits offerings.
The co... |
| 22.08.2017 | F-Prime Capital Leads $23.5M Series B for Stride Health | Stride Health, the leading benefits provider for independent workers, today announced a $23.5 million Series B financing round led by F-Prime Capital Partners, with participation from existing investors Venrock and New Enterprise Associates... |
| 22.08.2017 | Venrock Joins $23.5M Series B for Stride Health | Stride Health, the leading benefits provider for independent workers, today announced a $23.5 million Series B financing round led by F-Prime Capital Partners, with participation from existing investors Venrock and New Enterprise Associates... |
| 22.08.2017 | NEA Joins $23.5M Series B for Stride Health | Stride Health, the leading benefits provider for independent workers, today announced a $23.5 million Series B financing round led by F-Prime Capital Partners, with participation from existing investors Venrock and New Enterprise Associates... |
| 08.03.2017 | From real estate to healthcare: Trulia cofounder’s new health IT venture takes on Type 2 diabetes (Updated) | Two years after Zillow acquired online real estate company Trulia in a $2.5 billion deal, Trulia’s Cofounder and former president Sami Inkinen has moved into healthcare with the launch of telehealth startup, Virta Health. The digital health... |
| 13.02.2017 | The next big gold rush | Alon Bonder Contributor
Alon Bonder is a vice president at Venrock, investing in early-stage tech startups.
More posts by this contributor
The next big gold rush
If you’ve ever played Candy Crush on your smartphone during a morning commute,... |
| 09.02.2017 | Venrock Raises $450M Eighth Fund | Venrock has raised $450 million for an eighth fund, according to an SEC filing and news reports.
The fund is the same size as the firm’s seventh fund, which was raised in 2014. |
| 27.01.2017 | Venrock Closes Latest Venture Capital Fund, at $450M | Venrock, a NYC, Boston, MA and Palo Alto, California-based technology and healthcare focused venture capital firm, closed its latest fund, at $450m.
Venrock 8 will follow a similar strategy of the last several funds, partnering with entrepr... |
| 26.01.2017 | Venrock has raised $450 million for its eighth fund — just like its seventh fund | Venrock, the 47-year-old venture firm that started as the venture arm of the Rockefeller family, has closed its eighth fund with $450 million, which longtime partner Bryan Roberts calls “not too big and not too small, but just about right” ... |
| 26.01.2017 | Venrock has raised $450 million for its eighth fund —... | - |
| 26.01.2017 | Venrock raises a comfortable $450M for fund 8 | “It is a(nother) $450 million fund which feels, for us, a bit like the littlest bear’s bowl of porridge—not too big and not too small, but just about right.”
While there’s a tendency for VC firms to set successively higher goals and then br... |
| 26.01.2017 | Term Sheet — Thursday, January 26 | BIG, BRAZEN M&A
PE vs. Corporate: If yesterday’s last-minute buyout of AppDynamics is any indication, 2017 could be less about the return of big IPOs and more about the continuation of big, brazen M&A. That’s bad news for IPO banker... |
